Skip to main content
. 2017 Jul 24;9:433–442. doi: 10.2147/CEOR.S135065

Figure 3.

Figure 3

Cost (€) per patient by disease severity stages.

Notes: (A and B) Urothelial bladder cancer direct costs stratified by disease severity stages. The weighted average of these costs, based on patient distribution by disease severity stages, highlights that cost for a patient with superficial disease is €3,252, for a muscle-invasive and fit patient €2,539, for a muscle-invasive and unfit patient €1,606, and for metastatic disease is €606.